Retour

Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program

Health Health

Pre-treatment Sample of Patient’s Blood Showed Rapid and Potent Depletion of CD19+ B Cells in Ex Vivo Cytotoxicity Assay with FT819

GlobeNewswire Inc. • 09/05/2024 à 14:30:00
Fate Therapeutics, Inc.
Address: 12278 SCRIPPS SUMMIT DRIVE
Postal Code: 92131
City: SAN DIEGO
State: CA
Phone Number: 858.875.1803
Website: https://www.fatetherapeutics.com
Status: Active
Company Info

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

List Date2013-10-01
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001434316
Composite figiBBG000QP35H2
Share Class figiBBG001T888S2
Market Cap443,944,679 USD
SIC Code2836
SIC DescriptionBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Total Employees181
Share Class Shares Outstanding113830000
Weighted Shares Outstanding113831969
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
3.905
4.195
4.29
4.289
4.26
Variance
-6.71%
-2.21%
1.66%
1.08%
2.7%
Open
4.186
4.29
4.22
4.243
4.148
Highest
4.229
4.3
4.492
4.424
4.515
Lowest
4.201
4.3
4.471
4.41
4.505
History
PeriodVarhighestlowest
1 week
-5.86%
4.515
4.201
1 month
-20.82%
5.013
3.929
3 month
-48.65%
7.605
3.929
6 month
60.04%
2.7
2.1
1 year
-21.43%
5.33
1.63
3 year
-94.9%
78.86
1.63
5 year
-78.95%
19.05
1.63
10 year
-40.83%
6.6
1.46
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-08 2023-11-08 UNPUB
Assets 630,336,000 584,757,000 543,788,000 UNPUB
Current Assets 437,888,000 392,182,000 364,174,000 UNPUB
Current Liabilities 48,651,000 44,690,000 41,333,000 UNPUB
Equity 477,472,000 437,755,000 402,777,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 477,472,000 437,755,000 402,777,000 UNPUB
Liabilities 152,864,000 147,002,000 141,011,000 UNPUB
Liabilities And Equity 630,336,000 584,757,000 543,788,000 UNPUB
Noncurrent Assets 192,448,000 192,575,000 179,614,000 UNPUB
Noncurrent Liabilities 104,213,000 102,312,000 99,678,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-08 2023-11-08 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -19,313,000 4,732,000 -13,468,000 UNPUB
Net Cash Flow, Continuing -19,313,000 4,732,000 -13,468,000 UNPUB
Net Cash Flow From Financing Activities 207,000 58,000 0 UNPUB
Net Cash Flow From Financing Activities, Continuing 207,000 58,000 0 UNPUB
Net Cash Flow From Investing Activities 9,340,000 33,167,000 24,805,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 9,340,000 33,167,000 24,805,000 UNPUB
Net Cash Flow From Operating Activities -28,860,000 -28,493,000 -38,273,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -28,860,000 -28,493,000 -38,273,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-08 2023-11-08 UNPUB
Comprehensive Income/Loss -17,673,000 -52,696,000 -45,082,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -17,673,000 -52,696,000 -45,082,000 UNPUB
Other Comprehensive Income/Loss 1,208,000 -52,696,000 -45,082,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-08 2023-11-08 UNPUB
Basic Earnings Per Share 0 -1 0 UNPUB
Benefits Costs and Expenses 77,861,000 0 0 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 77,861,000 63,498,000 53,223,000 UNPUB
Diluted Earnings Per Share 0 -1 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -18,881,000 -52,755,000 -45,170,000 UNPUB
Income/Loss From Continuing Operations Before Tax -18,881,000 933,000 1,944,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -18,881,000 -52,755,000 -45,170,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -18,881,000 -52,755,000 -45,170,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -18,881,000 -52,755,000 -45,170,000 UNPUB
Operating Expenses 87,572,000 63,498,000 53,223,000 UNPUB
Operating Income/Loss -28,592,000 -62,565,000 -51,279,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 58,980,000 933,000 1,944,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Assets 858,386,000 807,059,000 749,349,000 705,561,000
Current Assets 599,075,000 599,157,000 535,329,000 502,074,000
Current Liabilities 77,911,000 91,518,000 103,938,000 114,051,000
Equity 633,393,000 580,483,000 518,003,000 483,939,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 633,393,000 580,483,000 518,003,000 483,939,000
Liabilities -633,393,000 -580,483,000 231,346,000 221,622,000
Liabilities And Equity 858,386,000 807,059,000 749,349,000 705,561,000
Noncurrent Assets 259,311,000 207,902,000 214,020,000 203,487,000
Noncurrent Liabilities 0 0 127,408,000 107,571,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -68,842,000 -9,466,000 26,818,000 -72,250,000
Net Cash Flow, Continuing -68,842,000 -9,466,000 26,818,000 -72,250,000
Net Cash Flow From Financing Activities 2,797,000 3,406,000 1,487,000 9,207,000
Net Cash Flow From Financing Activities, Continuing 2,797,000 3,406,000 1,487,000 9,207,000
Net Cash Flow From Investing Activities -7,026,000 40,287,000 80,378,000 166,751,000
Net Cash Flow From Investing Activities, Continuing -7,026,000 40,287,000 80,378,000 166,751,000
Net Cash Flow From Operating Activities -64,613,000 -53,159,000 -55,047,000 -248,208,000
Net Cash Flow From Operating Activities, Continuing -64,613,000 -53,159,000 -55,047,000 -248,208,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Comprehensive Income/Loss -67,778,000 -76,636,000 -83,435,000 -282,813,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -65,690,000 -76,105,000 -83,435,000 -282,813,000
Other Comprehensive Income/Loss 0 0 -83,435,000 -1,092,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Basic Earnings Per Share -1 -1 -1 -3
Benefits Costs and Expenses 84,104,000 0 0 378,021,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 84,104,000 101,658,000 101,372,000 378,021,000
Diluted Earnings Per Share -1 -1 -1 -3
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -65,690,000 -76,105,000 -83,563,000 -281,721,000
Income/Loss From Continuing Operations Before Tax -65,690,000 -76,105,000 14,981,000 -281,721,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -65,690,000 -76,105,000 -83,563,000 -281,721,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -65,690,000 -76,105,000 -83,563,000 -281,721,000
Net Income/Loss Available To Common Stockholders, Basic -65,690,000 -76,105,000 -83,563,000 -281,721,000
Operating Expenses 92,881,000 101,658,000 101,372,000 404,686,000
Operating Income/Loss -74,467,000 -83,109,000 -86,391,000 -308,386,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 18,414,000 18,549,000 14,981,000 96,300,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-04 2021-11-04 2022-02-28
Assets 1,045,964,000 1,015,666,000 984,571,000 921,455,000
Current Assets 804,316,000 713,268,000 693,713,000 633,412,000
Current Liabilities 94,577,000 105,600,000 91,884,000 81,284,000
Equity 790,095,000 752,071,000 730,332,000 678,838,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 790,095,000 752,071,000 730,332,000 678,838,000
Liabilities -790,095,000 -752,071,000 254,239,000 242,617,000
Liabilities And Equity 1,045,964,000 1,015,666,000 984,571,000 921,455,000
Noncurrent Assets 241,648,000 302,398,000 290,858,000 288,043,000
Noncurrent Liabilities 0 0 162,355,000 161,333,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-04 2021-11-04 2022-02-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -60,934,000 -29,759,000 52,526,000 -33,764,000
Net Cash Flow, Continuing -60,934,000 -29,759,000 52,526,000 -33,764,000
Net Cash Flow From Financing Activities 438,050,000 3,719,000 7,942,000 453,129,000
Net Cash Flow From Financing Activities, Continuing 438,050,000 3,719,000 7,942,000 453,129,000
Net Cash Flow From Investing Activities -471,888,000 -1,372,000 77,959,000 -324,023,000
Net Cash Flow From Investing Activities, Continuing -471,888,000 -1,372,000 77,959,000 -324,023,000
Net Cash Flow From Operating Activities -27,096,000 -32,106,000 -33,375,000 -162,870,000
Net Cash Flow From Operating Activities, Continuing -27,096,000 -32,106,000 -33,375,000 -162,870,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-04 2021-11-04 2022-02-28
Comprehensive Income/Loss -45,419,000 -54,959,000 -43,295,000 -212,983,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -45,089,000 -55,133,000 -43,295,000 -212,983,000
Other Comprehensive Income/Loss 0 0 -43,295,000 -832,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-04 2021-11-04 2022-02-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 56,231,000 0 0 267,997,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 56,231,000 60,191,000 68,848,000 267,997,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -45,089,000 -55,133,000 -43,308,000 -212,151,000
Income/Loss From Continuing Operations Before Tax -45,089,000 -55,133,000 14,225,000 -212,151,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB 0
Net Income/Loss -45,089,000 -55,133,000 -43,308,000 -212,151,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -45,089,000 -55,133,000 -43,308,000 -212,151,000
Net Income/Loss Available To Common Stockholders, Basic -45,089,000 -55,133,000 -43,308,000 -212,151,000
Operating Expenses 57,352,000 60,191,000 68,848,000 272,840,000
Operating Income/Loss -46,210,000 -46,779,000 -54,623,000 -216,994,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 11,142,000 13,412,000 14,225,000 55,846,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-05 2020-11-05 2021-02-24
Assets 321,890,000 653,594,000 626,443,000 622,457,000
Current Assets 208,249,000 540,225,000 496,777,000 494,323,000
Current Liabilities 24,924,000 45,322,000 54,195,000 85,564,000
Equity 219,218,000 474,111,000 424,365,000 384,445,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 219,218,000 474,111,000 424,365,000 384,445,000
Liabilities -219,218,000 -474,111,000 202,078,000 238,012,000
Liabilities And Equity 321,890,000 653,594,000 626,443,000 622,457,000
Noncurrent Assets 113,641,000 113,369,000 129,666,000 128,134,000
Noncurrent Liabilities 0 0 147,883,000 152,448,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-05 2020-11-05 2021-02-24
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -1,448,000 349,708,000 -83,944,000 82,533,000
Net Cash Flow, Continuing -1,448,000 349,708,000 -83,944,000 82,533,000
Net Cash Flow From Financing Activities 1,451,000 275,547,000 930,000 282,838,000
Net Cash Flow From Financing Activities, Continuing 1,451,000 275,547,000 930,000 282,838,000
Net Cash Flow From Investing Activities 23,774,000 35,320,000 -54,141,000 -161,076,000
Net Cash Flow From Investing Activities, Continuing 23,774,000 35,320,000 -54,141,000 -161,076,000
Net Cash Flow From Operating Activities -26,673,000 38,841,000 -30,733,000 -39,229,000
Net Cash Flow From Operating Activities, Continuing -26,673,000 38,841,000 -30,733,000 -39,229,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-05 2020-11-05 2021-02-24
Comprehensive Income/Loss -33,400,000 -27,591,000 -58,995,000 -173,339,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -33,520,000 -28,072,000 -58,995,000 -173,339,000
Other Comprehensive Income/Loss 0 0 -58,995,000 48,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-05 2020-11-05 2021-02-24
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 36,035,000 0 0 204,821,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 36,035,000 34,172,000 39,045,000 204,821,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -33,520,000 -28,072,000 -58,684,000 -173,387,000
Income/Loss From Continuing Operations Before Tax -33,520,000 -28,072,000 7,558,000 -173,387,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -33,520,000 -28,072,000 -58,684,000 -173,387,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -33,520,000 -28,072,000 -58,684,000 -173,387,000
Net Income/Loss Available To Common Stockholders, Basic -33,520,000 -28,072,000 -58,684,000 -173,387,000
Operating Expenses 37,007,000 34,172,000 39,045,000 159,519,000
Operating Income/Loss -34,492,000 -28,707,000 -31,487,000 -128,085,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 2,515,000 5,465,000 7,558,000 31,434,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-05 2020-03-02
Assets 220,865,000 199,877,000 340,207,000 302,274,000
Current Assets 186,430,000 165,178,000 305,633,000 227,089,000
Current Liabilities 29,140,000 29,418,000 40,595,000 27,806,000
Equity 145,837,000 127,526,000 268,042,000 244,756,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 145,837,000 127,526,000 268,042,000 244,756,000
Liabilities -145,837,000 -127,526,000 72,165,000 57,518,000
Liabilities And Equity 220,865,000 199,877,000 340,207,000 302,274,000
Noncurrent Assets 34,435,000 34,699,000 34,574,000 75,185,000
Noncurrent Liabilities 0 0 31,570,000 29,712,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-05 2020-03-02
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -7,481,000 -111,598,000 178,153,000 -90,700,000
Net Cash Flow, Continuing -7,481,000 -111,598,000 178,153,000 -90,700,000
Net Cash Flow From Financing Activities 1,258,000 688,000 161,705,000 149,928,000
Net Cash Flow From Financing Activities, Continuing 1,258,000 688,000 161,705,000 149,928,000
Net Cash Flow From Investing Activities 8,754,000 -91,977,000 36,286,000 -157,453,000
Net Cash Flow From Investing Activities, Continuing 8,754,000 -91,977,000 36,286,000 -157,453,000
Net Cash Flow From Operating Activities -17,493,000 -20,309,000 -19,838,000 -83,175,000
Net Cash Flow From Operating Activities, Continuing -17,493,000 -20,309,000 -19,838,000 -83,175,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-05 2020-03-02
Comprehensive Income/Loss -19,758,000 -23,385,000 -26,651,000 -98,125,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -19,760,000 -23,478,000 -26,609,000 -98,125,000
Other Comprehensive Income/Loss 0 0 0 24,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-06 2019-11-05 2020-03-02
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 108,829,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 23,078,000 26,901,000 29,548,000 108,829,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -19,760,000 -23,478,000 -26,609,000 -98,149,000
Income/Loss From Continuing Operations Before Tax 2,632,000 2,817,000 2,429,000 -98,149,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 405,000 409,000 400,000 1,752,000
Net Income/Loss -19,760,000 -23,478,000 -26,609,000 -98,149,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -19,760,000 -23,478,000 -26,609,000 -98,149,000
Net Income/Loss Available To Common Stockholders, Basic -19,760,000 -23,478,000 -26,609,000 -98,149,000
Operating Expenses 23,078,000 26,901,000 29,548,000 111,407,000
Operating Income/Loss -20,446,000 -24,084,000 -27,119,000 -100,727,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 2,632,000 2,817,000 2,429,000 10,680,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-06 2018-11-01 2019-03-05
Assets 93,420,000 83,155,000 219,954,000 213,032,000
Current Assets 90,625,000 80,034,000 213,929,000 205,196,000
Current Liabilities 12,588,000 16,273,000 22,672,000 27,263,000
Equity 64,995,000 51,825,000 173,929,000 160,469,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 64,995,000 51,825,000 173,929,000 160,469,000
Liabilities -64,995,000 -51,825,000 46,025,000 52,563,000
Liabilities And Equity 93,420,000 83,155,000 219,954,000 213,032,000
Noncurrent Assets 2,795,000 3,121,000 6,025,000 7,836,000
Noncurrent Liabilities 0 0 23,353,000 25,300,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-06 2018-11-01 2019-03-05
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -56,040,000 3,355,000 147,085,000 101,667,000
Net Cash Flow, Continuing -56,040,000 3,355,000 147,085,000 101,667,000
Net Cash Flow From Financing Activities 355,000 1,156,000 137,365,000 140,780,000
Net Cash Flow From Financing Activities, Continuing 355,000 1,156,000 137,365,000 140,780,000
Net Cash Flow From Investing Activities -43,844,000 13,722,000 13,276,000 -463,000
Net Cash Flow From Investing Activities, Continuing -43,844,000 13,722,000 13,276,000 -463,000
Net Cash Flow From Operating Activities -12,551,000 -11,523,000 -3,556,000 -38,650,000
Net Cash Flow From Operating Activities, Continuing -12,551,000 -11,523,000 -3,556,000 -38,650,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-06 2018-11-01 2019-03-05
Comprehensive Income/Loss -14,145,000 -19,656,000 -16,781,000 -66,597,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -14,135,000 -19,654,000 -16,782,000 -66,597,000
Other Comprehensive Income/Loss 0 0 0 1,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-06 2018-11-01 2019-03-05
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 71,338,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 15,080,000 20,632,000 17,718,000 71,338,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -14,135,000 -19,654,000 -16,782,000 -66,598,000
Income/Loss From Continuing Operations Before Tax 1,026,000 1,027,000 1,026,000 -66,598,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 412,000 425,000 429,000 1,696,000
Net Income/Loss -14,135,000 -19,654,000 -16,782,000 -66,598,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -14,135,000 -19,654,000 -16,782,000 -66,598,000
Net Income/Loss Available To Common Stockholders, Basic -14,135,000 -19,654,000 -16,782,000 -66,598,000
Operating Expenses 15,080,000 20,632,000 17,718,000 71,832,000
Operating Income/Loss -14,054,000 -19,605,000 -16,692,000 -67,092,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 1,026,000 1,027,000 1,026,000 4,740,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-14 2017-11-01 2018-03-05
Assets 85,329,000 73,952,000 72,675,000 105,292,000
Current Assets 83,437,000 71,861,000 70,039,000 102,596,000
Current Liabilities 16,897,000 8,052,000 9,716,000 11,049,000
Equity 63,858,000 55,213,000 45,749,000 77,189,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 63,858,000 55,213,000 45,749,000 77,189,000
Liabilities 21,471,000 18,739,000 26,926,000 28,103,000
Liabilities And Equity 85,329,000 73,952,000 72,675,000 105,292,000
Noncurrent Assets 1,892,000 2,091,000 2,636,000 2,696,000
Noncurrent Liabilities 4,574,000 10,687,000 17,210,000 17,054,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-14 2017-11-01 2018-03-05
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -48,001,000 -9,545,000 12,168,000 343,000
Net Cash Flow, Continuing -48,001,000 -9,545,000 12,168,000 343,000
Net Cash Flow From Financing Activities -2,170,000 -2,012,000 8,387,000 47,444,000
Net Cash Flow From Financing Activities, Continuing -2,170,000 -2,012,000 8,387,000 47,444,000
Net Cash Flow From Investing Activities -38,376,000 1,339,000 13,638,000 -10,196,000
Net Cash Flow From Investing Activities, Continuing -38,376,000 1,339,000 13,638,000 -10,196,000
Net Cash Flow From Operating Activities -7,455,000 -8,872,000 -9,857,000 -36,905,000
Net Cash Flow From Operating Activities, Continuing -7,455,000 -8,872,000 -9,857,000 -36,905,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-14 2017-11-01 2018-03-05
Comprehensive Income/Loss -10,159,000 -9,650,000 -10,658,000 -42,954,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -10,126,000 -9,645,000 -10,684,000 -42,954,000
Other Comprehensive Income/Loss 0 0 0 -42,954,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-15 2017-08-14 2017-11-01 2018-03-05
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 0
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 10,998,000 10,596,000 11,366,000 46,231,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -10,126,000 -9,645,000 -10,684,000 -42,952,000
Income/Loss From Continuing Operations Before Tax 1,027,000 1,026,000 1,026,000 4,106,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 266,000 212,000 378,000 1,268,000
Net Income/Loss -10,126,000 -9,645,000 -10,684,000 -42,952,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -10,126,000 -9,645,000 -10,684,000 -42,952,000
Net Income/Loss Available To Common Stockholders, Basic -10,126,000 -9,645,000 -10,684,000 -42,952,000
Operating Expenses 10,998,000 10,596,000 11,366,000 46,231,000
Operating Income/Loss -9,971,000 -9,570,000 -10,340,000 -42,125,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 1,027,000 1,026,000 1,026,000 4,106,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-09 2016-08-08 2016-11-07 2017-03-16
Assets 58,705,000 49,178,000 49,295,000 95,048,000
Current Assets 56,567,000 47,092,000 47,399,000 93,323,000
Current Liabilities 13,886,000 14,327,000 14,678,000 15,187,000
Equity 30,727,000 23,129,000 25,373,000 73,154,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 30,727,000 23,129,000 25,373,000 73,154,000
Liabilities 27,978,000 26,049,000 23,922,000 21,894,000
Liabilities And Equity 58,705,000 49,178,000 49,295,000 95,048,000
Noncurrent Assets 2,138,000 2,086,000 1,896,000 1,725,000
Noncurrent Liabilities 14,092,000 11,722,000 9,244,000 6,707,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-09 2016-08-08 2016-11-07 2017-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -25,322,000 -3,617,000 1,229,000 23,800,000
Net Cash Flow, Continuing -25,322,000 -3,617,000 1,229,000 23,800,000
Net Cash Flow From Financing Activities -1,726,000 -1,907,000 8,287,000 57,737,000
Net Cash Flow From Financing Activities, Continuing -1,726,000 -1,907,000 8,287,000 57,737,000
Net Cash Flow From Investing Activities -16,344,000 5,794,000 458,000 -4,114,000
Net Cash Flow From Investing Activities, Continuing -16,344,000 5,794,000 458,000 -4,114,000
Net Cash Flow From Operating Activities -7,252,000 -7,504,000 -7,516,000 -29,823,000
Net Cash Flow From Operating Activities, Continuing -7,252,000 -7,504,000 -7,516,000 -29,823,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-09 2016-08-08 2016-11-07 2017-03-16
Comprehensive Income/Loss -8,363,000 -8,411,000 -8,745,000 -33,463,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -8,377,000 -8,408,000 -8,737,000 -33,463,000
Other Comprehensive Income/Loss 0 0 0 -33,463,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-09 2016-08-08 2016-11-07 2017-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 0
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 9,238,000 9,031,000 9,415,000 36,365,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -8,377,000 -8,408,000 -8,737,000 -33,462,000
Income/Loss From Continuing Operations Before Tax 1,322,000 1,027,000 1,026,000 4,402,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 488,000 435,000 385,000 1,637,000
Net Income/Loss -8,377,000 -8,408,000 -8,737,000 -33,462,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -8,377,000 -8,408,000 -8,737,000 -33,462,000
Net Income/Loss Available To Common Stockholders, Basic -8,377,000 -8,408,000 -8,737,000 -33,462,000
Operating Expenses 9,238,000 9,031,000 9,415,000 36,365,000
Operating Income/Loss -7,916,000 -8,004,000 -8,389,000 -31,963,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 1,322,000 1,027,000 1,026,000 4,402,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-05 2015-11-03 2016-03-03
Assets 44,490,000 83,483,000 76,403,000 67,958,000
Current Assets 42,792,000 81,571,000 74,185,000 65,652,000
Current Liabilities 6,413,000 11,315,000 12,596,000 13,441,000
Equity 21,251,000 51,074,000 44,995,000 38,038,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 21,251,000 51,074,000 44,995,000 38,038,000
Liabilities 23,239,000 32,409,000 31,408,000 29,920,000
Liabilities And Equity 44,490,000 83,483,000 76,403,000 67,958,000
Noncurrent Assets 1,698,000 1,912,000 2,218,000 2,306,000
Noncurrent Liabilities 16,826,000 21,094,000 18,812,000 16,479,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-05 2015-11-03 2016-03-03
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -6,752,000 38,827,000 -8,319,000 15,708,000
Net Cash Flow, Continuing -6,752,000 38,827,000 -8,319,000 15,708,000
Net Cash Flow From Financing Activities 75,000 36,961,000 -533,000 35,603,000
Net Cash Flow From Financing Activities, Continuing 75,000 36,961,000 -533,000 35,603,000
Net Cash Flow From Investing Activities -452,000 -213,000 -655,000 -1,498,000
Net Cash Flow From Investing Activities, Continuing -452,000 -213,000 -655,000 -1,498,000
Net Cash Flow From Operating Activities -6,375,000 2,079,000 -7,131,000 -18,397,000
Net Cash Flow From Operating Activities, Continuing -6,375,000 2,079,000 -7,131,000 -18,397,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-05 2015-11-03 2016-03-03
Comprehensive Income/Loss -7,881,000 -7,779,000 -6,886,000 -29,992,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,881,000 -7,779,000 -6,886,000 -29,992,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-05 2015-11-03 2016-03-03
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 0
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 7,324,000 7,547,000 7,354,000 30,213,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -7,881,000 -7,779,000 -6,886,000 -29,992,000
Income/Loss From Continuing Operations Before Tax -7,881,000 329,000 1,026,000 2,431,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 558,000 563,000 562,000 2,220,000
Net Income/Loss -7,881,000 -7,779,000 -6,886,000 -29,992,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -7,881,000 -7,779,000 -6,886,000 -29,992,000
Net Income/Loss Available To Common Stockholders, Basic -7,881,000 -7,779,000 -6,886,000 -29,992,000
Operating Expenses 7,324,000 7,547,000 7,354,000 30,213,000
Operating Income/Loss -7,324,000 -7,218,000 -6,328,000 -27,782,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 329,000 1,026,000 2,431,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-12
Assets 49,649,000 43,551,000 47,010,000 51,204,000
Current Assets 48,263,000 42,245,000 45,624,000 49,872,000
Current Liabilities 4,354,000 3,812,000 3,912,000 4,581,000
Equity 45,177,000 39,638,000 33,576,000 28,340,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 45,177,000 39,638,000 33,576,000 28,340,000
Liabilities 4,472,000 3,913,000 13,434,000 22,864,000
Liabilities And Equity 49,649,000 43,551,000 47,010,000 51,204,000
Noncurrent Assets 1,386,000 1,306,000 1,386,000 1,332,000
Noncurrent Liabilities 118,000 101,000 9,522,000 18,283,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-12
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -6,155,000 -5,869,000 3,518,000 -4,935,000
Net Cash Flow, Continuing -6,155,000 -5,869,000 3,518,000 -4,935,000
Net Cash Flow From Financing Activities -502,000 -354,000 9,226,000 18,366,000
Net Cash Flow From Financing Activities, Continuing -502,000 -354,000 9,226,000 18,366,000
Net Cash Flow From Investing Activities -398,000 -26,000 -187,000 -882,000
Net Cash Flow From Investing Activities, Continuing -398,000 -26,000 -187,000 -882,000
Net Cash Flow From Operating Activities -5,255,000 -5,489,000 -5,521,000 -22,419,000
Net Cash Flow From Operating Activities, Continuing -5,255,000 -5,489,000 -5,521,000 -22,419,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-12
Comprehensive Income/Loss -6,980,000 -6,067,000 -6,603,000 -25,883,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -6,980,000 -6,067,000 -6,603,000 -25,883,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-12
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -6,980,000 -6,067,000 -6,603,000 -25,883,000
Income/Loss From Continuing Operations Before Tax -6,980,000 -6,067,000 -6,603,000 -25,883,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 43,000 28,000 187,000 549,000
Net Income/Loss -6,980,000 -6,067,000 -6,603,000 -25,883,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -6,980,000 -6,067,000 -6,603,000 -25,883,000
Net Income/Loss Available To Common Stockholders, Basic -6,980,000 -6,067,000 -6,603,000 -25,883,000
Operating Expenses 6,937,000 6,040,000 5,984,000 24,904,000
Operating Income/Loss -6,937,000 -6,040,000 -5,984,000 -24,904,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2014-03-17
Assets UNPUB UNPUB UNPUB 55,583,000
Current Assets UNPUB UNPUB UNPUB 54,651,000
Current Liabilities UNPUB UNPUB UNPUB 4,600,000
Equity UNPUB UNPUB UNPUB 50,848,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 50,848,000
Liabilities UNPUB UNPUB UNPUB 4,735,000
Liabilities And Equity UNPUB UNPUB UNPUB 55,583,000
Noncurrent Assets UNPUB UNPUB UNPUB 932,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 135,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2014-03-17
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB 44,949,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 44,949,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 60,560,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 60,560,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -238,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -238,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -15,373,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -15,373,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2014-03-17
Comprehensive Income/Loss UNPUB UNPUB UNPUB -20,894,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -20,894,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2014-03-17
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 0
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 18,646,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -20,894,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB 971,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB 796,000
Net Income/Loss UNPUB UNPUB UNPUB -20,894,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -20,894,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -20,894,000
Operating Expenses UNPUB UNPUB UNPUB 18,646,000
Operating Income/Loss UNPUB UNPUB UNPUB -17,675,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 971,000
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-5400.000
-17800.000
★
15:30
United States
-66000.000
-60000.000
★
15:30
United States
59500.000
53700.000
★
15:30
United States
-116600.000
-135800.000
★★
15:30
United States
3200.000
4400.000
★
15:30
United States
203000.000
215400.000
★
15:30
United States
200.000
-31400.000
★
15:30
United States
61800.000
62600.000
★
15:30
United States
1300.000
1300.000
★
15:30
United States
-25300.000
-9700.000
★
15:30
United States
204500.000
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:FATE240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:FATE240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:FATE240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:FATE240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:FATE240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:FATE240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:FATE240517P00012500 OPASPS Put American 100 12.5 BATO 2024-05-17
O:FATE240517P00010000 OPASPS Put American 100 10 BATO 2024-05-17
O:FATE240517P00015000 OPASPS Put American 100 15 BATO 2024-05-17
O:FATE240517C00015000 OCASPS Call American 100 15 BATO 2024-05-17
O:FATE240517C00012500 OCASPS Call American 100 12.5 BATO 2024-05-17
O:FATE240517C00010000 OCASPS Call American 100 10 BATO 2024-05-17
O:FATE240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:FATE240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:FATE240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:FATE240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:FATE240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:FATE240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:FATE240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:FATE240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:FATE240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:FATE240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:FATE240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:FATE240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:FATE240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:FATE240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:FATE240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:FATE240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:FATE240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:FATE240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:FATE240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:FATE240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:FATE240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:FATE240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:FATE240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:FATE240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:FATE240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:FATE240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:FATE240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:FATE240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:FATE240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:FATE240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:FATE240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:FATE240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:FATE240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:FATE240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:FATE231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:FATE231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:FATE231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:FATE231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:FATE231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:FATE231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:FATE231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:FATE231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:FATE231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:FATE231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:FATE231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:FATE231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:FATE231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:FATE231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:FATE231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:FATE231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:FATE231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:FATE231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:FATE231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:FATE231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:FATE230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:FATE230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:FATE230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:FATE230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:FATE230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:FATE230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:FATE230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:FATE230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:FATE230818P00025000 OPASPS Put American 100 25 BATO 2023-08-18
O:FATE230818P00022500 OPASPS Put American 100 22.5 BATO 2023-08-18
O:FATE230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:FATE230818P00017500 OPASPS Put American 100 17.5 BATO 2023-08-18
O:FATE230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:FATE230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:FATE230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:FATE230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:FATE230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:FATE230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:FATE230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:FATE230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
O:FATE230818C00025000 OCASPS Call American 100 25 BATO 2023-08-18
O:FATE230818C00022500 OCASPS Call American 100 22.5 BATO 2023-08-18
O:FATE230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
O:FATE230818C00017500 OCASPS Call American 100 17.5 BATO 2023-08-18
O:FATE230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:FATE230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:FATE230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:FATE230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:FATE230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:FATE230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Health Health
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
Pre-treatment Sample of Patient’s Blood Showed Rapid and Potent Depletion of CD19+ B Cells in Ex Vivo Cytotoxicity Assay with FT819
GlobeNewswire Inc. • 1w ago
Calendar Calendar of Events
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
Off-the-shelf, CD19-targeted CAR NK Cell Product Candidate Drives Rapid and Deep Depletion of SLE Donor CD19+ B cells
GlobeNewswire Inc. • 2w ago
Health Health
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
Key Therapeutic Mechanisms of Clinical Activity for Autoimmune Diseases, including B cell Depletion, Tissue Infiltration and Immune Reconstitution Data, from Phase 1 Study of FT819 in Relapsed / Refractory B-cell Malignancies to be Highlighted
GlobeNewswire Inc. • 3w ago
Analyst Analyst Ratings
Where Fate Therapeutics Stands With Analysts
6 analysts have shared their evaluations of Fate Therapeutics (NASDAQ:FATE) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 4 1 0 Last 30D 0 0 0 0 0 1M Ago 0 0 1 1 0 2M Ago 0 1 3 0 0 3M Ago 0 0 0 0 0 Analysts have set 12-month price targets for Fate Therapeutics, revealing an average target of $7.33, a high estimate of $10.00, and a low estimate of $6.00. Marking an increase of 83.25%, the current average surpasses the previous average price target of $4.00. Diving into Analyst Ratings: An In-Depth Exploration The perception of Fate Therapeutics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Tazeen Ahmad B of A Securities Raises Underperform $6.00 $2.00 Raghuram Selvaraju HC Wainwright & Co. Maintains Neutral $7.00 - Michael Ulz Morgan Stanley Raises Equal-Weight $7.00 $3.00 Etzer Darout BMO Capital Raises Market Perform $7.00 $6.00 Peter Lawson Barclays Raises Overweight $10.00 $6.00 David Nierengarten Wedbush Raises Neutral $7.00 $3.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Fate Therapeutics. This information offers a snapshot of how analysts perceive the current state ...Full story available on Benzinga.com
Benzinga • 1mo ago
Stocks Changes in company's own shares
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that on April 1, 2024 the Company granted restricted stock units (RSUs) representing 6,400 shares of its common stock to one newly-hired non-executive employee. The grant was approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
GlobeNewswire Inc. • 1mo ago
News News
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Research • 1mo ago
stocks News
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Research • 1mo ago
Stocks Warrants and Certificates
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced the pricing of an underwritten offering of 14,545,454 shares of its common stock at an offering price of $5.50 per share. The offering includes participation from new and existing institutional investors, including Adage Capital Partners LP., Boxer Capital, Deep Track Capital, OrbiMed, Suvretta Capital and a life-sciences focused investor.
GlobeNewswire Inc. • 2mo ago
Analyst Analyst Ratings
Evaluating Fate Therapeutics: Insights From 5 Financial Analysts
5 analysts have expressed a variety of opinions on Fate Therapeutics (NASDAQ:FATE) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 1 3 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Analysts have recently evaluated Fate Therapeutics and provided 12-month price targets. The average target is $7.6, accompanied by a high estimate of $10.00 and a low estimate of $7.00. This current average reflects an increase of 68.89% from the previous average price target of $4.50. Interpreting Analyst Ratings: A Closer Look The analysis of recent analyst actions sheds light on the perception of Fate Therapeutics by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Raghuram Selvaraju HC Wainwright & Co. Maintains Neutral $7.00 - Michael Ulz Morgan Stanley Raises Equal-Weight $7.00 $3.00 Etzer Darout BMO Capital Raises Market Perform $7.00 $6.00 Peter Lawson Barclays Raises Overweight $10.00 $6.00 David Nierengarten Wedbush Raises Neutral $7.00 $3.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it ...Full story available on Benzinga.com
Benzinga • 2mo ago
Stocks Changes in company's own shares
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company granted a non-qualified stock option to one newly-hired employee to purchase a total of 40,000 shares of the Company’s common stock at an exercise price per share of $7.74, which was the closing price per share of the Company’s common stock as reported by NASDAQ on the grant effective date of March 1, 2024. The option was approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The option vests over four years, with 25% vesting on the one-year anniversary of the grant date and the remaining 75% percent vesting in approximately equal monthly installments over the following thirty-six months, subject to the employee being continuously employed by the Company through each vesting date.
GlobeNewswire Inc. • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT